News Overview

Lumax Industries Limited has informed the Exchange about Closure of trading window.

APL Apollo Tubes Limited has informed the Exchange about press release dated 28-Nov-2022 titled APL Apollo Tubes achieves 80th Percentile in industry in S&P Global Corporate Sustainability Assessment (CSA) 2022

The Exchange had sought clarification from Dollar Industries Limited with respect to announcement dated approving Employees Stock Option (ESOP) Scheme, 2022. On the basis of aforesaid announcement, the Company was required to provide/clarify the following: 1. Brief details of options granted 2. Whether the scheme is in terms of SEBI (SBEB) Regulations, 2014 (if applicable); 3. Total number of shares covered by these options; 4. Pricing formula; 5. Options vested; 6. Time within which option may be exercised; 7. Brief details of significant terms; The response of the company is attached.

Wanbury Limited has informed the Exchange about the Board Meeting held on 28-Nov-2022 to consider financial statements for the half year and quarter ended September 2022.

Bank Of India has informed the Exchange about Voting results of Postal Ballot

Aptus Value Housing Finance India Limited has informed the Exchange that Board of Directors at its meeting held on 28-Nov-2022, declared Dividend of Rs. 2 per equity share.

Jindal Stainless (Hisar) Limited has informed the Exchange about Notice of Postal Ballot

Hinduja Global Solutions Limited has informed the Exchange about Investor Presentation

Members of the Exchange are hereby notified that the suspension in trading of the securities of Mafatlal Finance Limited (Symbol: MAFATLAFIN) will be revoked w.e.f. December 05, 2022, on account of satisfactory redressal of issues of non-compliance of the erstwhile Listing Agreement and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 under new name Hybrid Financial Services Limited (Symbol: HYBRIDFIN) with new issue size 29436275 and new ISIN INE965B01022.

Zydus Lifesciences Limited has informed the Exchange about press release dated 28-Nov-2022 titled Zydus receives tentative approval from the USFDA for Levothyroxine Sodium for Injection